Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia | Zendy

Natacha Bellanger | Zendy; Alexina Orsoni | Zendy; Zélie Julia | Zendy; Natalie Fournier | Zendy; Éric Frisdal | Zendy; Emilie Duchêne | Zendy; Éric Bruckert | Zendy; Alain Carrié | Zendy; Dominique Bonnefont–Rousselot | Zendy; John Pirault | Zendy; Flora Saint-Charles | Zendy; M. John Chapman | Zendy; Philippe Lesnik | Zendy; Wilfried Le Goff | Zendy; Maryse Guérin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Atheroprotective Reverse Cholesterol Transport Pathway Is Defective in Familial Hypercholesterolemia

Author(s) -

Natacha Bellanger,

Alexina Orsoni,

Zélie Julia,

Natalie Fournier,

Éric Frisdal,

Emilie Duchêne,

Éric Bruckert,

Alain Carrié,

Dominique Bonnefont–Rousselot,

John Pirault,

Flora Saint-Charles,

M. John Chapman,

Philippe Lesnik,

Wilfried Le Goff,

Maryse Guérin

Publication year - 2011

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.111.227181

Subject(s) - cholesterylester transfer protein , reverse cholesterol transport , scavenger receptor , abcg1 , cholesterol , abca1 , efflux , chemistry , apolipoprotein b , endocrinology , cholesteryl ester , medicine , lipoprotein , familial hypercholesterolemia , high density lipoprotein , biochemistry , transporter , gene

Low high-density lipoprotein (HDL) cholesterol levels are frequently observed in familial hypercholesterolemia (FH) and might be associated with functional alterations of HDL particles that may influence their efficaciousness in the reverse cholesterol transport pathway.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research